corticobasal syndrome (cbs)
Showing 1 - 4 of 4
Corticobasal Syndrome (CBS) Trial (RAVICTI 1.1 g/ml, Placebo)
Not yet recruiting
- Corticobasal Syndrome (CBS)
- RAVICTI 1.1 g/ml
- Placebo
- (no location specified)
Aug 1, 2023
Frontotemporal Lobar Degeneration (ARTFL)
Completed
- FTLD
- +11 more
-
Birmingham, Alabama
- +16 more
May 18, 2021
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Recruiting
- Corticobasal Degeneration (CBD)
- +5 more
- Observational Study
-
San Diego, California
- +7 more
May 18, 2021
Primary Four Repeat Tauopathies (4RT), Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy (PSP) Trial in Birmingham,
Completed
- Primary Four Repeat Tauopathies (4RT)
- +3 more
- TPI 287 2 mg/m2
- +3 more
-
Birmingham, Alabama
- +1 more
Apr 13, 2020